Novocure Gmbhpark 6ch 6039 Root D4 Pma Numberp100034 Supplement Numbers029 Date Received02 14 2022 Decision Date05 10 2022 Product Code Nzk Advisory Committee Neurology Supplement Typenormal 180 Day Track Supplement Reason Change Design Components Specifications Material Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Novocure Gmbhpark 6ch 6039 Root D4 Pma Numberp100034 Supplement Numbers029 Date Received02 14 2022 Decision Date05 10 2022 Product Code Nzk Advisory Committee Neurology Supplement Typenormal 180 Day Track Supplement Reason Change Design Components Specifications Material Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P100034S029 Novocure GmbHpark 6ch-6039 Root D4  PMA NumberP100034 Supplement NumberS029 Date Received02/14/2022 Decision Date05/10/2022 Product Code NZK  Advisory Committee Neurology Supplement Typenormal 180 Day Track Supplement Reason Change Design/components/specifications/material Expedited Review Granted? No	Optune® device	2022-05-10